recognition in various patient populations (studies on US cancer patients are bold and italicized). Factor(s)/Study Location/Settin
g Sample characteristics Domain(s) Relevant study findings Rahman et. al
(2015)1 inpatients Pakistan/ Adults hospitalized for in medical and surgical wards in a Pakistani tertiary care center.
Depressi
on Null
Lee et. al (2014)2 Korea/Commu
nity Depressed adults that participated in the Korea National Health and Nutrition Examination Survey.
Depressi
on Null.
Zhao et. al (2014)3 China/Inpatien
ts Cancer inpatients in a university hospital in Beijing. Cancer sites of interest included lung, digestive tract, breast, liver, ovarian and uterine cancer.
Depression recognition was more likely in married patients and those with metastatic cancer.
Hudson et. al
(2013)4 USA/Outpatient Diabetics from Kaiser Permanente Northern California.
Depressi
on Depression recognition was more likely in whites compared to blacks.
Zhang et. al
(2010)5 USA/Community Elderly colorectal cancer patients in
SEER-Medicare data.
Depressi on and anxiety
Depression recognition was more likely in whites, the elderly and females.
Luppa et al
(2008)6 Germany/Outpatient Elderly primary care patients in Germany. Depression Null Rifel et. al (2008) 7 Slovenia/
Outpatient Adults seeking care at family practices. Depression Depression recognition was more likely in females and in individuals with higher levels of education. Stockdale et. al
(2008)8 USA/Outpatient Analyses of data on office-based visits from the National
Ambulatory Medical Care Study from 1995 – 2005.
Depressi on and anxiety
Depression recognition was more likely in whites than in African Americans and Hispanics.
Teh et. al (2008)9 USA/Commu nity
Participants in the National Survey of Alcohol, Drug, and Mental Health Problems.
Depressi on
Depression recognition was more likely in patients with at least one medical
129
Amin et. al(2006)10 USA/Inpatient Adult patients hospitalized for acute coronary syndrome.
Depressi on
Depression recognition was more likely in whites and in patients with at least some college education.
Ell et. al (2005)11 USA/Outpatient Ovarian and
gynecological cancer survivors receiving care at an urban public medical center.
Depressi on
Depression recognition was less likely in women with low-Income or from racial minorities.
Gallo et. al
(2005)12 USA/Outpatient Elderly patients visiting primary care providers. Depression Depression recognition was more likely in whites. Rabinowitz et. al
(2005)13 Israel/Outpatient Elderly primary care patients. Psychological distress
Depression recognition was more likely in females, in those with severe
psychological distress, and in those who visited the clinic every week. Wittchen et. al
(2001)14 Germany/Outpatient Adults seeking care from pre-selected primary care providers on a pre-specified day in April 1999.
Depressi on
Depression recognition was more likely in the elderly and the employed.
Thompson et. al
(2001)15 UK/Outpatient Adults visiting general practitioners. Depression Depression recognition was more likely in participants that were employed. Bertakis et. al
(2001) 16 USA/Outpatient Men initiating care at primary care practices. Depression Depression recognition was more likely in those with more severe depression, those with more clinic visits, those with more education, and those that were separated, divorced or widowed.
Borowsky et. al
(2000)17 USA/Outpatient Adults visiting ambulatory clinics in practices participating in a larger Medical
Outcomes Study (MOS).
Depressi
on Depression recognition was more likely in females, whites (compared to African Americans and Hispanics), and in those with coexisting
hypertension. Simon et. al
(1999)18 15 countries/ Outpatient Depressed adult participants at primary care clinics.
Depressi on
Depression recognition was more likely in females. Callahan et. al
(1997)19 USA/Outpatient Adults initiating care at primary care practices. Depression Depression recognition was more likely in females, in those with more severe
130
depression and in those with more education. Garrard et. al
(1998)20 USA/Community Community-dwelling elderly enrollees in a managed care
organization.
Depressi on
Depression recognition was more likely in females and in those with more severe depression.
131
Appendix Box 1.1: Web links to PCaP/HCaP-NC questionnaires
1. Baseline: https://pcap.bioinf.unc.edu/files/PCaP_Questionnaire_and_Citation.pdf
2. Follow-up year 1: https://pcap.bioinf.unc.edu/files/follow-up-Y1qx.pdf
3. Follow-up year 2: https://pcap.bioinf.unc.edu/files/follow-up-Y2qx.pdf
132
Appendix Table 1.2: State of the evidence on variables associated with both PCRA and HRQOL Consistent evidence of
associations with both PCRA and HRQOL
Inconsistent evidence of associations with both PCRA and HRQOL
No evidence of associations with both PCRA and HRQOL Bone pain from metastatic
lesions 21
PSA level 21-27 Education 22,25-27
Time since cancer treatment 28,29 Age 21-28,30 Income and employment 22,29,31 Cancer stage at diagnosis
21,23,24,26,27
Marital status 22-24,28 Lifestyle and sexual orientation22,32
Depression or anxiety 25,26,30 Personality traits (e.g. neuroticism) 22,33
Source of health care 22 PSA progression group (stable vs
other) 26,28
Involvement of the prostate capsule or seminal vesicles 23,24
Treatment decision making 34 Race/Ethnicity 23,24 Tumor classification 22
Gleason score 23,24 Family history of prostate cancer 23,24
Cancer treatment modality 23,24,35 Residence 27
Comorbidities e.g. diabetes23,24 Nerve sparing23,24
133
REFERENCES1. Rahman AS, Aziz A, Jamal Q, Siddiqui MA. Prevalence of unrecognized depression in patients admitted in medical and surgical departments of a tertiary care hospital: a comparative analysis, Karachi, Pakistan. 2015.
2. Lee H, Cho KS, Yoon J, Park HS. Factors associated with self-reported depression, diagnosis, and treatment among Korean adults. Korean Journal of Health Promotion. 2014;14(1):9-16. 3. Zhao L, Li X, Zhang Z, et al. Prevalence, correlates and recognition of depression in Chinese
inpatients with cancer. General hospital psychiatry. 2014;36(5):477-482.
4. Hudson DL, Karter AJ, Fernandez A, et al. Differences in the clinical recognition of depression in diabetes patients: The Diabetes Study of Northern California (DISTANCE). The American journal of managed care. 2013;19(5):344.
5. Zhang AY, Cooper GS. Recognition of depression and anxiety among elderly colorectal cancer patients. Nursing research and practice. 2010;2010.
6. Luppa M, Heinrich S, Angermeyer MC, König H-H, Riedel-Heller SG. Healthcare costs associated with recognized and unrecognized depression in old age. International Psychogeriatrics. 2008;20(06):1219-1229.
7. Rifel J, Švab I, Šter MP, Pavlič DR, King M, Nazareth I. Impact of demographic factors on recognition of persons with depression and anxiety in primary care in Slovenia. BMC psychiatry.
2008;8(1):96.
8. Stockdale SE, Lagomasino IT, Siddique J, McGuire T, Miranda J. Racial and ethnic disparities in detection and treatment of depression and anxiety among psychiatric and primary health care visits, 1995–2005. Medical care. 2008;46(7):668.
9. Teh CF, Reynolds CF, Cleary PD. Quality of depression care for people with coincident chronic medical conditions. General hospital psychiatry. 2008;30(6):528-535.
10. Amin AA, Jones AM, Nugent K, Rumsfeld JS, Spertus JA. The prevalence of unrecognized depression in patients with acute coronary syndrome. American heart journal. 2006;152(5):928- 934.
11. Ell K, Sanchez K, Vourlekis B, et al. Depression, correlates of depression, and receipt of
depression care among low-income women with breast or gynecologic cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(13):3052-3060. 12. Gallo JJ, Bogner HR, Morales KH, Ford DE. Patient ethnicity and the identification and active
management of depression in late life. Archives of internal medicine. 2005;165(17):1962-1968. 13. Rabinowitz J, Shayevitz D, Hornik T, Feldman D. Primary care physicians' detection of
psychological distress among elderly patients. The American journal of geriatric psychiatry.
2005;13(9):773-780.
14. Wittchen H-U, Höfler M, Meister W. Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? International clinical
134
15. Thompson C, Ostler K, Peveler RC, BAKER N, Kinmonth A-l. Dimensional perspective on the recognition of depressive symptoms in primary care. The British Journal of Psychiatry.
2001;179(4):317-323.
16. Bertakis KD, Helms LJ, Callahan EJ, Azari R, Leigh P, Robbins JA. Patient gender differences in the diagnosis of depression in primary care. Journal of women's health & gender-based medicine.
2001;10(7):689-698.
17. Borowsky SJ, Rubenstein LV, Meredith LS, Camp P, Jackson‐Triche M, Wells KB. Who is at risk of nondetection of mental health problems in primary care? Journal of general internal medicine. 2000;15(6):381-388.
18. Simon GE, Goldberg D, Tiemens BG, Ustun TB. Outcomes of recognized and unrecognized depression in an international primary care study. General hospital psychiatry. 1999;21(2):97- 105.
19. Callahan EJ, Bertakis KD, Azari R, Helms LJ, Robbins J, Miller J. Depression in primary care: patient factors that influence recognition. Family Medicine. 1997;29(3):172-176.
20. Garrard J, Rolnick SJ, Nitz NM, et al. Clinical detection of depression among community-based elderly people with self-reported symptoms of depression. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 1998;53(2):M92-M101.
21. Johanes C, Monoarfa RA, Ismail RI, Umbas R. Anxiety level of early-and late-stage prostate cancer patients. Prostate international. 2013;1(4):177-182.
22. van den Bergh RC, Essink‐Bot ML, Roobol MJ, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer. 2009;115(17):3868-3878.
23. Tavlarides AM, Ames SC, Thiel DD, Diehl NN, Parker AS. Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer. Psycho-oncology.
2015;24(4):451-457.
24. Tavlarides AM, Ames SC, Diehl NN, et al. Evaluation of the association of prostate cancer- specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Psycho-oncology. 2013;22(6):1328- 1335.
25. Dale W, Hemmerich J, Bylow K, Mohile S, Mullaney M, Stadler WM. Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study. Journal of Clinical Oncology. 2009;27(10):1557-1563.
26. Roth A, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX– PC). Psychosomatics. 2006;47(4):340-347.
27. Huang Q, Jiang P, Zhang Z, et al. Assessing cancer-specific anxiety in Chinese men with prostate cancer: psychometric evaluation of the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2017.
135
28. Meissner VH, Herkommer K, Marten-Mittag B, Gschwend JE, Dinkel A. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy. Journal of Cancer Survivorship.
2017:1-8.
29. Pearce SM, Wang CH, Victorson DE, et al. A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate Cancer. Sexual medicine. 2015;3(3):156- 164.
30. Roth AJ, Rosenfeld B, Kornblith AB, et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer.
2003;97(11):2910-2918.
31. Nelson CJ, Starr TD, Macchia RJ, Hyacinthe L, Friedman S, Roth AJ. Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2016;24(7):2905-2911.
32. Ussher JM, Perz J, Kellett A, et al. Health-related quality of life, psychological distress, and sexual changes following prostate cancer: a comparison of gay and bisexual men with heterosexual men. The journal of sexual medicine. 2016;13(3):425-434.
33. van den Bergh RC, Essink-Bot M-L, Roobol MJ, Schröder FH, Bangma CH, Steyerberg EW. Do anxiety and distress increase during active surveillance for low risk prostate cancer? The Journal of urology. 2010;183(5):1786-1791.
34. Goh AC, Kowalkowski MA, Bailey Jr DE, Kazer MW, Knight SJ, Latini DM. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. BJU international.
2012;110(2b).
35. Fleshner NE, Lucia MS, Egerdie B, et al. Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. The Lancet.
136
APPENDIX 2: SUPPLEMENTAL TEXT FOR CHAPTER 2 SECTION 2.11